
Dayhoff Technologies helps researchers quickly turn fragmented genomic data into meaningful therapeutic insights. It uses an AI-powered bioinformatics platform focusing on shotgun metagenomics and microbiome analysis, offered as a pay-per-use SaaS. The system supports secure collaboration while maintaining HIPAA and SOC2 compliance. The technology enables secure data processing and storage, reducing analysis time from months to days and lowering costs. The company targets the $20.7B bioinformatics market and serves research institutions and pharmaceutical companies.

Dayhoff Technologies helps researchers quickly turn fragmented genomic data into meaningful therapeutic insights. It uses an AI-powered bioinformatics platform focusing on shotgun metagenomics and microbiome analysis, offered as a pay-per-use SaaS. The system supports secure collaboration while maintaining HIPAA and SOC2 compliance. The technology enables secure data processing and storage, reducing analysis time from months to days and lowering costs. The company targets the $20.7B bioinformatics market and serves research institutions and pharmaceutical companies.